Company / Capital Returned to Shareholders per Share
Amphstar Pharmaceuticals, Inc. Capital Returned to Shareholders per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Returned to Shareholders per Share
$1.59
FY2025
5-year range
$0.61 / $1.78
FY2021-FY2025
Trend
-10.7%
vs FY2024
Sector context
#20 of 51
Health Care
What the data says
At $1.59, Amphstar Pharmaceuticals, Inc.'s capital returned to shareholders per share ranks #20 of 51 in the Health Care sector. Capital Returned to Shareholders per Share has fluctuated over the past 10 years, ranging from $0.22 in FY2016 to $1.78 in FY2024.
Based on SEC 10-K filings.
1.59 in FY2025 with a 5-year CAGR of +24.8%.
Improved from $1.21 to $1.59 over the past 2 years.
Health Care sector context is included.
Capital Returned to Shareholders per Share over time
Growth rates
- 3-Year CAGR
- +23.8%
- 5-Year CAGR
- +24.8%
- 10-Year CAGR
- -
Sector benchmark
-42.0% below sector average
Key checks
Key Insights
- In FY2025, capital returned to shareholders per share decreased 10.7% year-over-year.
- Ranks #20 out of 51 companies in the Health Care sector.
- Peak capital returned to shareholders per share was recorded in FY2024.
- Lowest capital returned to shareholders per share in the period was in FY2016.
Company context
Key Data Points
- Strong profit margin: 21.8%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital Returned to Shareholders per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.59 | -10.7% |
| FY2024 | $1.78 | +47.1% |
| FY2023 | $1.21 | +44.5% |
| FY2022 | $0.84 | +37.6% |
| FY2021 | $0.61 | +15.9% |
| FY2020 | $0.52 | +9.7% |
| FY2019 | $0.48 | -11.0% |
| FY2018 | $0.54 | -19.2% |
| FY2017 | $0.66 | +203.3% |
| FY2016 | $0.22 | -0.8% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026